Clinical speed Q-linea's ASTar rapid antimicrobial susceptibility testing delivers results within six hours from a positive blood culture, enabling faster targeted therapy and potential collaborations with hospitals seeking to reduce time to optimal therapy.

Antibiotic stewardship The fast, precise susceptibility profiles help hospitals cut broad-spectrum antibiotic use, presenting a sales angle with infection control teams and pharmacy departments focused on stewardship initiatives and cost containment.

Regulatory readiness ASTar is CE-IVD certified and US-FDA cleared, signaling a credible, accessible pathway for expansion into European and North American markets and facilitating conversations with clinical directors and procurement teams.

SMB focus With 51–200 employees and revenue in the 1–10 million range, Q-linea sits in a segment receptive to scalable lab automation solutions; partnerships with mid-sized hospitals and regional labs could yield rapid adoption and reference sites.

Tech stack fit Leveraging automation, data analytics, and cloud-enabled workflows (e.g., JSON-LD, Python integrations) can be positioned to IT and QA teams as compatible with existing lab information systems and compliance requirements.